| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and COO | Chief Operating Officer
1 company
Holli Cherevka last filed a Form 4 in January 2022, as President and COO at AMPE. Holli Cherevka's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 410,820 shares of AMPE. The AMPE filings lean toward selling, a net 77,234 shares.
Holli Cherevka has 8 Form 4 filings on record from October 2018 to January 2022, all as President and COO at Ampio Pharmaceuticals (AMPE), 2018–2022.
The 22 reported transactions were 8 option or other derivative awards, 6 dispositions back to the company, 3 option exercises and 2 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $154K.
The largest open-market sale was 74,631 shares of AMPE at an average $2.00 on April 27, 2021, about $149K.
Shares as reported in the last Form 4 for each company; the most recent is from January 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.